CA-GILEAD-SCIENCES
28.3.2022 17:02:07 CEST | Business Wire | Press release
Gilead Sciences, Inc., (Nasdaq: GILD) today announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education and support local communities most impacted by the HIV epidemic and COVID-19 pandemic. The Zeroing In: Ending the HIV Epidemic program, will support 116 organizations in 41 countries. The funding recipients will focus on advancing at least one of three focus areas: Comprehensive HIV Innovation, Digital Health Innovation and Community Outreach and Education.
“While the HIV community has made tremendous progress toward ending the HIV epidemic, the COVID-19 pandemic created barriers and amplified health inequities in the most marginalized communities,” said Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences. “We are working with organizations that will reach under-resourced communities and support them to find innovative, effective solutions. Zeroing In programs aim to increase access to HIV care and services and build on Gilead’s efforts to help end the epidemic for everyone, everywhere.”
“Through Gilead Sciences’ Zeroing In program, a collective of 10 migrant-led frontline organizations across Europe have the opportunity to work collectively for the first time to address HIV knowledge, testing and treatment barriers amongst migrant communities,” said Denis Onyango, Programmes Director, Africa Advocacy Foundation.
“Through this funding, we will be able to increase community awareness of HIV and PrEP to marginalized communities across Mississippi, through trained community health workers. We plan to address HIV stigma, and structural and institutional barriers associated with HIV care in Mississippi. It is only through support from organizations like Gilead that we will truly be able to end the HIV epidemic,” said Dr. Christopher Roby, Chief Operations Officer, Community Health Center Association of Mississippi.
“This funding will empower very isolated families to manage their HIV at home and to quickly access medical care when additional support is needed, without creating undue financial burdens on families that are experiencing significant hardship. It will also help us combat the devastating stigma that exists around HIV throughout Nepal. This will make it easier to access care, maintain community ties, and keep safe and healthy,” said Crystal Anderson, Grants and Donor Communications Manager, Nepal Youth Foundation.
To build on progress in local communities, Zeroing In organizations will prioritize populations most affected by the HIV epidemic. This includes projects from local organizations collaborating to end the HIV epidemic in their respective cities, states, countries or regions. Zeroing In organizations will focus on one or more of three areas:
- Comprehensive HIV Innovation Programs: This includes at-home testing efforts that help close the gaps in HIV testing and prevention, supportive service programs and comprehensive HIV prevention programs inclusive of biomedical prevention options.
- Digital Health Innovations : Strategies will address the health literacy divide in accessing digital health services, support digital access in rural areas for better outcomes for people living with HIV, or support digital health education for those with language barriers, aging populations, indigenous, migrant and stigmatized populations.
- Community Outreach and Education: Community-driven programs will provide resources for HIV community outreach workers, address the lack of culturally appropriate service options, break down barriers between communities and service providers, and reduce stigma and improve education around HIV.
About Zeroing In
Zeroing In builds on previous Gilead funding and grant programs, while supporting organizations to increase the overall health and wellness of communities most impacted by HIV and COVID-19. Gilead provides support to organizations whose programs align with international and country-specific Ending the HIV Epidemic goals. This includes local community programming and coalition-led proposals from organizations collaborating to end the HIV epidemic in their respective city, state, country or region. Zeroing In programming focuses on comprehensive HIV innovation, digital health innovation, and/or community outreach and education.
For more information on Gilead’s Zeroing In: Ending the HIV Epidemic grant program, please visit https://www.gilead.com/purpose/giving/zeroing-in-ending-hiv-epidemic . A complete list of funded organizations can be found at https://www.gilead.com/-/media/files/pdfs/other/Zeroing-In-Grantee-List-for-Website.pdf .
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more than 30 years, Gilead has been a leading innovator in the field of HIV, driving advances in treatment, prevention and cure research. Today, millions of people living with HIV globally receive antiretroviral therapy provided by Gilead or one of the company’s manufacturing partners.
GILEAD and the GILEAD logo are trademarks of Gilead Sciences, Inc. All other trademarks are the property of their respective owners.
For more information about Gilead, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@Gilead Sciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220325005437/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FEINDEF 27 Accelerates Commercialisation, Surpassing FEINDEF 25’s Total Exhibition Area by 25% With One Year to Go17.6.2026 13:41:00 CEST | Press release
FEINDEF 27 is expected to exceed 89,000 m² of total exhibition area, representing a 46% increase compared to 2025 and further strengthening its position as one of Europe’s leading international defence and security exhibitions. 37% of the exhibitors already confirmed are new participants. Of these, 26% are international companies, reinforcing FEINDEF’s global dimension and its role as a platform for dialogue, cooperation and business opportunities at an international level. Companies returning from the previous edition have increased their contracted exhibition area for FEINDEF 27 by 30%, consolidating confidence in FEINDEF as a global showcase for the sector. This trend was already reflected in FEINDEF 25, where 86% of exhibitors stated their intention to return. One year ahead of FEINDEF 27, FEINDEF, Spain’s International Defence and Security Exhibition, continues to maintain a strong commercialisation pace, outperforming previous editions at the same stage. The exhibition has alread
GenNx360 Capital Partners Promotes Pratik Rajeevan to Partner17.6.2026 13:00:00 CEST | Press release
GenNx360 Capital Partners (“GenNx360”), a New York City-based private equity firm investing in U.S. lower middle market industrial services and business services companies, is thrilled to announce the promotion of Pratik Rajeevan to Partner. Pratik has significant transaction experience having invested in over ten platform companies and 30 add-on investments during his tenure at GenNx360. His experience includes investments in aerospace and defense, utility and environmental services, and testing and inspection services. Pratik is a key leader in investments in NVI, Shenandoah, and Aeron in the GenNx360 Fund IV portfolio. Pratik led successful investments and exits in Miller Environmental and Aero3 in GenNx360 Fund III. Most recently, Pratik was responsible for the firm’s $2 billion exit from Precision Aviation Group, a global aerospace and defense maintenance and repair business in GenNx360 Fund IV. “Pratik is a disciplined and thoughtful investor with significant execution capabiliti
Vercel Brings New Agent Framework, Full-Stack Capabilities, and Enterprise Controls to Its Agentic Infrastructure Platform17.6.2026 12:13:00 CEST | Press release
As agents become the primary way software is built and deployed, Vercel connects its frontend, backend, and agent tooling into a single platform for shipping and running agents at scale. Today at Ship, its annual conference, Vercel introduced a set of new products that deepen its agentic infrastructure platform trusted by DoorDash, Helly Hansen, OpenAI, Stripe, and The Weather Company. Founder and CEO Guillermo Rauch and other Vercel leaders unveiled the lineup on stage, anchored by three shifts the products address: agents are now the dominant way software gets deployed, every application is becoming agentic, and enterprises need to run agents in production securely and at scale. The transition is well underway. Six months ago, fewer than three percent of deployments to Vercel infrastructure were triggered by coding agents. Agents now account for more than half. Token volume through Vercel's AI Gateway has grown from roughly two trillion to twenty trillion per month over the same peri
NIQ Introduces NIQ Cadence: A Compound AI Operating System for Marketing Effectiveness17.6.2026 12:00:00 CEST | Press release
One system unifies NIQ’s global data, models, and knowledge so marketers move from insight to impact faster, with deeper intelligence, at scale. NIQ (NYSE: NIQ), a global leader in consumer intelligence, today introduced NIQ Cadence, a compound AI operating system built to change how organizations measure marketing performance, optimize budgets, and act on what the data tells them. NIQ Cadence brings data and intelligence into one continuous environment, moving marketers off fragmented reports and onto a single system that empowers decision making. Marketing has never been more complex. Channels keep multiplying, data sits in silos, and the pressure to prove ROI keeps climbing. As a result, most teams still stitch insight and action together by hand, losing time and confidence at every handoff. NIQ Cadence closes that gap with one system where measurement and decision-making finally run together. “Marketing leaders don’t need more reports. They need a better rhythm,” said Jason Tate, G
Winning With AI Requires Organizational Transformation, Not Speed of Adoption, Finds New Arthur D. Little Report17.6.2026 12:00:00 CEST | Press release
To successfully embrace the power of AI, businesses need to remove organizational complexity and eliminate unnecessary work, rather than simply using it for fragmented, incremental improvements. Boards must act now to deliver this. That is the key message from AI-First or Disrupted: Beating the Nightmare Competitor, a new report from Arthur D. Little (ADL) based on concrete examples from leading organizations. Within three to five years, AI-first competitors will make faster decisions, have flatter organizations, and operate at lower costs. They will not just optimize handovers between teams, approvals, and reconciliation work; they will eliminate these complex processes entirely. AI is completely changing the economics of work and value creation, removing the need for coordination across multiple teams, while also enabling adaptive, predictive, and personalized products and services. This delivers both lower operational costs and a fundamentally stronger value proposition. However, mo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom